Cargando…
Protein- and Peptide-Based Virus Inactivators: Inactivating Viruses Before Their Entry Into Cells
Infectious diseases caused by human immunodeficiency virus (HIV) and other highly pathogenic enveloped viruses, have threatened the global public health. Most antiviral drugs act as passive defenders to inhibit viral replication inside the cell, while a few of them function as gate keepers to combat...
Autores principales: | Su, Xiaojie, Wang, Qian, Wen, Yumei, Jiang, Shibo, Lu, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261908/ https://www.ncbi.nlm.nih.gov/pubmed/32523582 http://dx.doi.org/10.3389/fmicb.2020.01063 |
Ejemplares similares
-
A Peptide-Based Virus Inactivator Protects Male Mice Against Zika Virus-Induced Damage of Testicular Tissue
por: Si, Lulu, et al.
Publicado: (2019) -
Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry
por: He, Yuxian, et al.
Publicado: (2004) -
Inactivation of foodborne viruses by novel organic peroxyacid-based disinfectants
por: Bouchard, Simon, et al.
Publicado: (2023) -
A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses
por: Yu, Yufeng, et al.
Publicado: (2017) -
Editorial: Enteric Viruses in Food: Survival and Inactivation Methods
por: Randazzo, Walter, et al.
Publicado: (2021)